dc.contributor.author |
Xodjimetova Iroda Xamidullaevna, Karimov Ma’rif Shakirovich |
|
dc.date.accessioned |
2024-12-28T04:04:09Z |
|
dc.date.available |
2024-12-28T04:04:09Z |
|
dc.date.issued |
2024-12-27 |
|
dc.identifier.uri |
http://repo.tma.uz/xmlui/handle/1/821 |
|
dc.description.abstract |
This study focused on evaluating the role of matrix metalloproteinase 9 (MMP-9) in the progression of rheumatoid arthritis (RA) and its potential impact on liver function. Sixty patients, split into a main group and a control group, wore analysed through a combination of clinical, laboratory, and imaging assessments. Elevated MMP-9 levels were found to be associated with more severe disease progression, including higher rates of hypertension, stroke, and ischaemic heart disease in the main group. These findings suggest that MMP-9 could serve as a valuable biomarkcr for predicting RA severity and liver pathology. The study recommends early detection and continuous monitoring of MMP-9 to guide treatment strategics. Future research should further investigate MMP-9’s role in RA-rclated liver dysfunction and explore the development of therapies aimed at modulating MMP-9 levels to improve patient outcomes. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.subject |
rheumatoid arthritis, matrix metalloproteinases. |
en_US |
dc.title |
"SIGNIFICANCE OF EXTRACELLULAR BIOCHEMICAL MARKERS IN RHEUMATOID ARTHRITIS AND THEIR IMPACT ON LIVER FUNCTION" |
en_US |
dc.title.alternative |
"Patient-Centered Approaches to Medical Intervention Proceedings of International Conference September 27 & 28, 2024 I Online I Worldwide" |
en_US |
dc.type |
Article |
en_US |